Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...
The PROSTaid group, which meets monthly at The Cradock Arms in Leicester, aims to create a support group for men so they can ...
Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...
Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...
An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.
This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
2don MSN
Israeli hospital's groundbreaking studies could lessen treatments, reduce prostate cancer risks
A groundbreaking study at Rabin Medical Center suggests prostate cancer patients may need only two radiation doses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results